fbpx

Neurodegenerative Disease Models

Preselected Neurodegenerative Disease-Relevant Models

The ability to quickly install variant alleles in C. elegans and zebrafish, and quantitatively measure the variant phenotypes provides researchers a path to rapidly address the consequence of gene variation for answering questions of neurodegenerative disease biology.

The images below illustrate C. elegans as a transgenic model for studying gene variations associated with Alzheimer’s Disease (AD), Frontotemporal Dementia (FD), and Epilepsy Disorder (ED).

C. elegans as a transgenic model for studying Alzheimer’s Disease (AD) and Frontotemporal Dementia (FD). Red text: AD human genes expressed with worm gene homologue (in parentheses). Purple text: FD human gene express with worm gene homologue (in parentheses). Phenotypes observed are written close to the arrow.

C. elegans as a transgenic model for studying Alzheimer’s Disease (AD) and Frontotemporal Dementia (FD).
Red text: AD human genes expressed with worm gene homologue (in parentheses).
Purple text: FD human gene express with worm gene homologue (in parentheses).
Phenotypes observed are written close to the arrow.

C. elegans as a transgenic model for studying Epilepsy Disorder (ED).
Green Text: ED human genes expressed with worm gene homologue (in parentheses).

Featured Offerings

We have preselected disease-relevant models and validated their genetic identity with PCR and sequencing. These humanized model systems can serve as another efficient tool set to study human diseases.

Models for Alzheimer’s Disease

Strains carrying genetic mutations that are associated with Alzheimer’s disease, validated via PCR and sequencing.

Models for Epilepsy Disorder

Models carrying genetic mutations that are associated with Epilepsy disorder, validated via PCR and sequencing.

Other Offerings

We can create other neurodegenerative disease-relevant models using zebrafish and C. elegans, including Frontotemporal Degeneration and Huntington's diseases.

READY TO GET STARTED?

Ready to connect with us to learn more about working with our company or our technology?

Scroll to Top